Veterinary Medicine Information website

EURICAN DAP-LMULTI LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION

Not authorised
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
  • Canine parvovirus, strain CAG2, Live
  • Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
Download as PDF

Product identification

Medicine name:
EURICAN DAP-LMULTI LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION
Active substance:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
  • Canine parvovirus, strain CAG2, Live
  • Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain DK13, Live
    316.23
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine distemper virus, strain BA5, Live
    10000.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain CAG2, Live
    79432.80
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Romania
Package description:
  • Plastic box of 25 vials (glass) of lyophilisate (1 dose) and 25 vials (glass) of suspension (1 ml)
  • Plastic box of 50 vials (glass) of lyophilisate (1 dose) and 50 vials (glass) of suspension (1 ml)
  • Plastic box of 10 vials (glass) of lyophilisate (1 dose) and 10 vials (glass) of suspension (1 ml)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 200135
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0287/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 20/07/2022
Download

eu-puar-frv0287001-mr-rpe668-en.pdf

English (PDF)
Published on: 13/03/2026
Download